BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32847550)

  • 1. Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma.
    Yu X; Li X; Xing Y; Lu S; Tanumiharjo S; Ma J
    BMC Cancer; 2020 Aug; 20(1):808. PubMed ID: 32847550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
    Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
    Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
    Rao R; Honavar SG; Sharma V; Reddy VAP
    Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding.
    Koç İ; Taylan Şekeroğlu H; Kıratlı H; Lotfisadigh S
    Eur J Ophthalmol; 2022 May; 32(3):1766-1771. PubMed ID: 34082595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periocular topotecan for vitreous seeds in retinoblastoma.
    Sthapit PR; Rao R; Honavar SG
    Indian J Ophthalmol; 2018 Dec; 66(12):1833-1838. PubMed ID: 30451190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars plana vitrectomy in eyes treated for retinoblastoma.
    Warden SM; Mukai S
    Retina; 2006 Sep; 26(7 Suppl):S53-6. PubMed ID: 16946680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track.
    Munier FL; Soliman S; Moulin AP; Gaillard MC; Balmer A; Beck-Popovic M
    Br J Ophthalmol; 2012 Aug; 96(8):1084-7. PubMed ID: 22368262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial Chemotherapy for Adult Onset Retinoblastoma in a 32-Year-Old Man.
    Magan T; Khoo CT; Jabbour PM; Fuller DG; Shields CL
    J Pediatr Ophthalmol Strabismus; 2016 Jul; 53():e43-6. PubMed ID: 27486894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç İ; Varan A; Akyüz C
    Eur J Ophthalmol; 2017 Jun; 27(4):423-427. PubMed ID: 28106239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M
    Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL
    Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma.
    Miller DM; Murray TG; Cicciarelli NL; Capo H; Markoe AM
    Ophthalmology; 2005 Sep; 112(9):1620-4. PubMed ID: 16024083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.